What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Prostate cancer
Chris H. Bangma spends much of his time researching Prostate cancer, Internal medicine, Gynecology, Prostate-specific antigen and Cancer.
His Prostate cancer study focuses on Prostatectomy in particular.
The concepts of his Internal medicine study are interwoven with issues in Surgery and Oncology.
His biological study spans a wide range of topics, including Medical physics, Prostate cancer screening and Randomization.
As a member of one scientific family, Chris H. Bangma mostly works in the field of Prostate-specific antigen, focusing on Mass screening and, on occasion, Transrectal ultrasonography.
He interconnects Exosome, Microvesicles, Nephrology and Magnetic resonance imaging in the investigation of issues within Cancer.
His most cited work include:
- Screening and Prostate-Cancer Mortality in a Randomized European Study (3160 citations)
- Prostate-Cancer Mortality at 11 Years of Follow-up (964 citations)
- Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study (377 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Prostate and Cancer.
His Prostate cancer research is multidisciplinary, incorporating elements of Biopsy, Gynecology and Urology.
Chris H. Bangma works mostly in the field of Urology, limiting it down to topics relating to Pathology and, in certain cases, Urine.
His research on Internal medicine frequently links to adjacent areas such as Surgery.
In the subject of general Oncology, his work in Nomogram is often linked to Context, thereby combining diverse domains of study.
His Prostate study combines topics in areas such as Cancer research and Metastasis.
He most often published in these fields:
- Prostate cancer (70.31%)
- Internal medicine (52.81%)
- Oncology (33.75%)
What were the highlights of his more recent work (between 2015-2021)?
- Prostate cancer (70.31%)
- Internal medicine (52.81%)
- Biopsy (15.62%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Prostate cancer, Internal medicine, Biopsy, Prostatectomy and Oncology.
He is studying Prostate-specific antigen, which is a component of Prostate cancer.
His Biopsy research is multidisciplinary, relying on both Stage, Prostate biopsy, Medical physics and Disease.
The various areas that he examines in his Prostatectomy study include Pathology, Surgical margin, Cribriform, Hazard ratio and Radiation therapy.
His Oncology study integrates concerns from other disciplines, such as Biomarker and Biochemical recurrence.
The Cancer study combines topics in areas such as Immunoassay, Endocrinology, Hyperplasia and Gynecology.
Between 2015 and 2021, his most popular works were:
- Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force (108 citations)
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer (95 citations)
- Active surveillance for prostate cancer: a narrative review of clinical guidelines (94 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His scientific interests lie mostly in Prostate cancer, Internal medicine, Biopsy, Prostate-specific antigen and Prostate.
His research on Prostate cancer concerns the broader Cancer.
Chris H. Bangma focuses mostly in the field of Cancer, narrowing it down to matters related to Gynecology and, in some cases, Stage.
His Internal medicine research incorporates elements of Oncology and MEDLINE.
Within one scientific family, Chris H. Bangma focuses on topics pertaining to Prostate biopsy under Prostate-specific antigen, and may sometimes address concerns connected to Proportional hazards model, Genetic predisposition, Prostate cancer screening and PSA Velocity.
His Prostate research includes themes of Radiology and Receiver operating characteristic.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
